Spero Therapeutics
SPRO
SPRO
54 hedge funds and large institutions have $23.7M invested in Spero Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
83% less capital invested
Capital invested by funds: $143M → $23.7M (-$119M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
54
Holding in Top 10
–
Calls
$60K
Puts
–
Top Buyers
| 1 | +$719K | |
| 2 | +$528K | |
| 3 | +$528K | |
| 4 |
Man Group
London,
United Kingdom
|
+$368K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$140K |
Top Sellers
| 1 | -$941K | |
| 2 | -$698K | |
| 3 | -$592K | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$242K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$87.6K |